Page last updated: 2024-08-21

psilocybin and Affective Disorders

psilocybin has been researched along with Affective Disorders in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Day, K; Galvão-Coelho, NL; Perkins, D; Pinzon Rubiano, D; Sarris, J1
de Manincor, M; Galvão-Coelho, NL; Gonzalez, M; Marx, W; Perkins, D; Sarris, J; Sinclair, J1
Mertens, LJ; Preller, KH1
Aixalà, M; Bouso, JC; Dos Santos, RG; Hallak, JEC1
De Gregorio, D; Enns, JP; Gobbi, G; Nuñez, NA; Posa, L1
Flynn, S; Frowde, KD; Jelen, LA; Rucker, JJ; Young, AH1

Reviews

5 review(s) available for psilocybin and Affective Disorders

ArticleYear
Psychedelic medicines for mood disorders: current evidence and clinical considerations.
    Current opinion in psychiatry, 2022, 01-01, Volume: 35, Issue:1

    Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Disorders; Psilocybin; Psychotherapy

2022
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.
    Psychopharmacology, 2021, Volume: 238, Issue:2

    Topics: Affect; Banisteriopsis; Depression; Depressive Disorder, Major; Double-Blind Method; Hallucinogens; Healthy Volunteers; Humans; Lysergic Acid Diethylamide; Mood Disorders; Psilocybin; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome

2021
Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.
    Pharmacopsychiatry, 2021, Volume: 54, Issue:4

    Topics: Hallucinogens; Humans; Mood Disorders; Psilocybin; Psychiatry; Substance-Related Disorders

2021
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
    Progress in brain research, 2018, Volume: 242

    Topics: Animals; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Disorders; Psilocybin

2018
Psychedelics in the treatment of unipolar mood disorders: a systematic review.
    Journal of psychopharmacology (Oxford, England), 2016, Volume: 30, Issue:12

    Topics: Depressive Disorder, Treatment-Resistant; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Disorders; Pilot Projects; Psilocybin; Treatment Outcome

2016

Other Studies

1 other study(ies) available for psilocybin and Affective Disorders

ArticleYear
Psychedelics and Personality.
    ACS chemical neuroscience, 2018, 10-17, Volume: 9, Issue:10

    Topics: Anxiety Disorders; Banisteriopsis; Clinical Trials as Topic; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Disorders; N,N-Dimethyltryptamine; Personality; Plant Preparations; Psilocybin; Receptor, Serotonin, 5-HT2A; Substance-Related Disorders

2018